Trial intelligence / Profile preview

High-Dose Vitamin D with Chemoradiotherapy in Glioblastoma

NCT01181193Phase 2Unknown

Sponsor
Soroka University Medical Center
Start
Mar 2011
Primary completion
Mar 2013
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of vitamin d in glioblastoma multiforme (GBM), sponsored by Soroka University Medical Center. Status: unknown.

02

Drugs

vitamin d
03

Conditions

glioblastoma multiforme (GBM)

Beyond the preview

Go deeper on NCT01181193.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01181193.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call